(Update) Report on Symposium “Global Health and Corporate Strategy: Varied and Innovative Models”
date : 12/25/2012
The symposium “Global Health and Corporate Strategy: Varied and Innovative Models” was hosted in collaboration with the GAVI Alliance and UNICEF Tokyo Office.
With
the IMF/World Bank annual general meetings was held in Tokyo in October,
attention was drawn toward the major agenda of investments into health. Under
this increased momentum, the emphasis at this symposium was on partnerships
within corporations and various organizations particularly for the solving of
global health problems. The merits, barriers and solutions to such partnerships
was discussed through the sharing of successful examples, and with a focus on
the impact produced by international social action that utilized the special
features of businesses and varied and innovative approaches it was aspired to
help solve global health problems.
(Please download our report, program and questionnaire from the right )
(You can see some parts of videos on the day from here (YouTube).)
GAVI – HGPI – UNICEF Collaborative Symposium
“Global Health and Corporate Strategy: Diverse, Innovative Partnership Models”
■Date : Thursday, October 11, 2012 from 15:00~18:00
■Venue : Fujifilm
Corporation / Midtown West Conference room (2F)
■Co-organizers: GAVI Alliance/ Health and Global Policy Institute (HGPI)/
UNICEF Tokyo Office
■Supported by the
Ministry of Foreign Affairs of Japan
■In cooperation with : RESULTS Japan
■Program
1. Opening Remarks(15:00-15:10)
– Dr. Seth Berkley (CEO, GAVI Alliance)
2. Keynote Speeches
Keynote Speeches 1(15:10-15:40)
–
Dr. Kiyoshi Kurokawa (Chairman, HGPI)
Keynote Speeches 2(15min.)
–
Dr. Tadataka Yamada(Member of the Board, Chief Medical & Scientific
Officer, Takeda Pharmaceutical Company Limited)
Break (15:40-16:00)
3. Panel Discussion: Multi-Stakeholder Partnerships in Global
Health(16:00-17:40)
Moderator: Mr. Koichi Kaneda (Senior Director, Corporate Social
Responsibility, Corporate Communication, Takeda Pharmaceutical Company Limited)
1) “Partnership Case Study –Ghana Project–”
– Dr. Yasuhiko Toride, Director of Nutrition Improvement
Projects / Associate General Manager, R&D Planning Dept., Ajinomoto Co.,
Inc.
2) “Partnership Case Study –Anti-Infective Drug–”
– Dr. Junichi Mitsuyama, Senior Operations Manager, FUJIFILM
Corporation / Director, Toyama Chemical Co., Ltd.
3) “Partnership Case Study –Vaccine &
Medicine Development for NTDs through Partnership–“
– Dr.
BT Slingsby (Director of Global Access Strategies,
Eisai Co., Ltd.)
4) “Partnership Case Study –Vaccine Bonds–”
– Mr. Satoru Yamamoto, Director, Head of International
Investors Services, FICC Sales Dept (I), Daiwa Securities
5) “Promoting Global Partnership for
Children–Case Studies and Considerations–”
– Dr. Kunihiko Chris Hirabayashi (Director, United Nations Children’s Fund Tokyo office)
Discussion (50 min)
4. Wrap-up(17:40-17:55)
– Dr. Seth Berkley (CEO, GAVI Alliance)
– Dr. Dr. Tadataka Yamada(Member of the Board, Chief Medical & Scientific
Officer, Takeda Pharmaceutical Company Limited)
– Dr. Kiyoshi Kurokawa (Chairman, HGPI)
5. Closing Remarks
– Dr.
Shiro Konuma (Director, Global Health Policy Division International Cooperation Bureau
Ministry of Foreign Affairs)(17:55-18:00)
Contact Details:
GAVI – HGPI – UNICEF Collaborative Symposium Japan Secretariat
Health and Global Policy Institute
1-11-28 Nagatacho,Chiyoda-Ku Tokyo 100-0014 Japan
E-mail: symposium1011@hgpi.org
Normal 0 0 2 false false false EN-US JA X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:標準の表; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:””; mso-padding-alt:0mm 5.4pt 0mm 5.4pt; mso-para-margin:0mm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.5pt; mso-bidi-font-size:11.0pt; font-family:”Century”,”serif”; mso-ascii-font-family:Century; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Century; mso-hansi-theme-font:minor-latin; mso-font-kerning:1.0pt;}
Registration deadline: 2012-10-09
Exhibition date:2012-10-11
Top Research & Recommendations Posts
- [Policy Recommendations] Joint Statement “Protecting the Health of Both the Planet and People — A Japan-Model Planetary Health Strategy to Turn the Climate Crisis into an Opportunity for Health, the Economy, and Growth” (June 24, 2026)
- [Policy Recommendations] Toward Further Advancement of Measures Against Antimicrobial Resistance (AMR) (July 15, 2026)
- [Announcement] HGPI Joins the UHC2030 Task Force for the 2027 UN High-Level Meeting on UHC (July 6, 2026)
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Research Report] AMR Policy Update #6: The New Global Action Plan on AMR (Part 1)
- [Research Report] AMR Policy Update #7: The New Global Action Plan on AMR (Part 2)
- [Policy Recommendations] Hearing Loss Project “Recommendations on Coherent Countermeasures for Hearing Loss Throughout the Life Course: Building a Society Where Everyone Can Access Appropriate Hearing Care” (July 30, 2026)
- [Research Report] AMR Policy Update #9: Stockholm Residents’ Awareness and Practices in Returning and Recycling Pharmaceuticals: Findings from Local Interviews (July 15, 2026)
- [Policy Recommendations] Expectations for a System that Spans Diseases, Ministries, and Agencies for the Effective Promotion of Patient and Public Involvement (PPI) in Research and Development (June 30, 2026)
- [Activity Report] HGPI Contributed to the Development of the Civil 7 (C7) Global Health Working Group’s Climate and Health Thematic Brief for the G7 (June 25, 2026)
Featured Posts
-
2026-06-19
[Recommendations] Strengthening Epidemiology Education in the Veterinary Field for the One Health Era (June 19, 2026)
-
2026-07-21
[Announcement] Announcement of the 2nd Kiyoshi Kurokawa Award Recipient
-
2026-07-22
[Registration Open] Second Session of the Planetary Health Academy (Starts September 2026)
-
2026-07-31
[Policy recommendation] Reliable Policy Implementation for Early Detection and Early Intervention of Chronic Kidney Disease (CKD) (July 31, 2026)
-
2026-08-05
[Registration Open] (Webinar) The 4th J-PEP Seminar “The History of PPI in Japan and My Own PPI Journey” (September 30, 2026)



